Home

clusterrandomized

Cluster randomized, or cluster-randomized trials (CRTs), are experiments in which intact groups or clusters are assigned to intervention or control conditions rather than individual participants. Clusters may be defined by geographic units such as villages or districts, institutions such as schools or clinics, or other natural groupings. Interventions are often delivered at the cluster level, while outcomes are typically measured at the individual level. CRTs are frequently used when individual randomization is impractical or when there is a risk of contamination among participants within the same cluster.

Key design considerations include the distinction between the unit of randomization and the unit of analysis.

Common designs encompass parallel CRTs, where clusters are randomized to arms and followed over time, and stepped-wedge

Analysis methods must account for clustering. Approaches include mixed-effects (multilevel) models with random cluster effects, generalized

Ethical and practical considerations involve consent at both cluster and individual levels, potential equitable access to

The
number
of
clusters
and
the
average
cluster
size
strongly
influence
power;
outcomes
within
a
cluster
tend
to
be
correlated,
quantified
by
the
intra-cluster
correlation
coefficient
(ICC).
This
correlation
reduces
the
effective
sample
size,
described
by
the
design
effect,
and
necessitates
more
clusters
rather
than
merely
more
individuals.
Unequal
cluster
sizes
complicate
sample
size
calculations
and
analyses.
CRTs,
in
which
all
clusters
eventually
receive
the
intervention
but
at
different
time
points.
Other
designs
include
factorial
CRTs
and,
less
frequently,
cluster-based
cross-over
trials
with
attention
to
carryover
effects.
estimating
equations
with
robust
standard
errors,
or
cluster-level
summaries.
Intention-to-treat
principles
are
typically
applied,
and
reporting
should
include
ICC
estimates,
design
effects,
number
of
clusters,
and
handling
of
baseline
imbalances.
interventions,
and
adherence
to
reporting
guidelines
such
as
CONSORT
extensions
for
cluster
trials.